Radiation delivered over several sessions reduced recurrence for large brain metastases, and an experimental SERD may delay progression in estrogen receptor-positive breast cancer.

by Darlene Dobkowski

The ‘Your Friends & Neighbors’ actress explains how her diagnosis challenged many of her assumptions about breast cancer.

by Darlene Dobkowski

An FDA committee supports a liquid biopsy that screens for up to 50 cancers, and the FDA approves a drug combo for certain people with breast cancer.

by Thomas Celona

When doctors told Yvonne McLean Florence she was eligible to participate in a research trial testing an experimental drug, she joined. She wants more people to have the same opportunity.

by Yvonne McLean Florence

MRI surveillance for brain metastases helps preserve cognition in small cell lung cancer, and an AACR report calls for sustained research funding.

by Eric Fitzsimmons

Cancer care aid enrollments for people near the World Trade Center site tripled in recent years, and the FDA approved an oral SERD for ESR1-mutated breast cancer.

by Darlene Dobkowski

A recently approved drug that targets RAS proteins meaningfully improves outcomes for people with this difficult-to-treat cancer.

by Sandra Gordon

The FDA approves two therapies to treat rare blood cancers, and U.S. cervical cancer screening rates decline.

by Thomas Celona

A surfer’s love for the ocean guides her through breast cancer treatment and beyond.

by Cameron Walker

The FDA approves a RAS-targeted therapy, and government-funded research explores topics often neglected by industry trials.

by Eric Fitzsimmons